Study on Integrated Nursing Strategy for Patients With Gastrointestinal Stromal Tumors After Targeted Therapy

Phase

N/A

Condition

Gastrointestinal Diseases And Disorders

Gastric Cancer

Abdominal Cancer

Treatment

N/A

Clinical Study ID

NCT05665868

2022-LCYJ-MS-30

Ages > 18
All Genders

Study Summary

The goal of this clinical trial is to construct a symptom management strategy for patients with gastrointestinal stromal tumor targeted therapy based on symptom management theory under the guidance of MRC framework. Embed the symptom management strategy into the information platform and conduct an empirical study on integrated care for GIST patients, and compare it with the traditional outpatient follow-up patients to explore the safety and effectiveness of the symptom management strategy and the application effect of the integrated care platform.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Patients diagnosed as gastrointestinal stromal tumor and receiving targeted therapy
Over 18 years old, with normal communication ability
Will use smart phones, or the family members who will use smart phones willlive in the meeting
Informed consent and voluntary participation in this study.

Exclusion

Exclusion Criteria:

Patients with psychiatric history or congenital mental retardation
The patient or his/her cohabiting family members cannot complete the healthstatus self test, health status assessment and questionnaire under the prompts ofthe platform. Criteria for case termination:
Those who voluntarily put forward termination during the study period and areunwilling to accept follow-up or refuse to fill in the questionnaire
Death
Lost subjects

Study Design

April 01, 2022

April 01, 2025

Study Description

The purpose of this clinical trial is to build an information platform for symptom management and integrated care strategy of gastrointestinal stromal tumor targeted treatment patients: the system is composed of big data platform and care strategy platform. The big data platform can automatically extract patient data from HIS, Medcare and other patient diagnosis and treatment systems according to the pre-set patient inclusion criteria, form a health file of gastrointestinal stromal tumor targeted treatment patients, and complete the enrollment. The system will intelligently promote the care strategies of the patients included in the big data platform, promote the two-way communication between doctors and patients, and realize the functions of timed symptom evaluation, symptom management, symptom management result feedback, etc. All patient health data can be customized output through the big data platform. The two platforms complement each other, promote patient self-management, improve the quality of medical follow-up service, reduce the workload of medical personnel, optimize the use of medical resources, and improve the quality of scientific research data. It is not necessary for patients to judge how to take intervention measures, but the system's management center decision-making module will evaluate the symptoms of patients, and then pop up corresponding measures, so that patients can more effectively cope with the discomfort of related symptoms caused by targeted treatment at home, and alleviate the impact on life.

Connect with a study center

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu 210000
China
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.